{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:47:57Z","timestamp":1786736877580,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Neurosci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jpn.jpn_133_18","type":"journal-article","created":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T09:53:11Z","timestamp":1593337991000},"page":"81","source":"Crossref","is-referenced-by-count":6,"title":["Effect of levetiracetam usage on serum creatine phosphokinase concentration in patients with epilepsy"],"prefix":"10.4103","volume":"15","author":[{"given":"Faruk","family":"Incecik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OzlemM","family":"Herguner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyda","family":"Besen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1817-1745.288298-1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.seizure.2007.02.004","article-title":"Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy","author":"Grosso","year":"2007","journal-title":"Seizure"},{"key":"key-10.4103\/1817-1745.288298-2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpn.2007.09.004","article-title":"Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study","author":"Callenbach","year":"2008","journal-title":"Eur J Paediatr Neurol"},{"key":"key-10.4103\/1817-1745.288298-3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ckj\/sfs023","article-title":"Levetiracetam-induced severe acute granulomatous interstitial nephritis","author":"Chau","year":"2012","journal-title":"Clin Kidney J"},{"key":"key-10.4103\/1817-1745.288298-4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.0013-9580.2004.64903.x","article-title":"Levetiracetam-induced thrombocytopenia","author":"Kimland","year":"2004","journal-title":"Epilepsia"},{"key":"key-10.4103\/1817-1745.288298-5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ebcr.2014.08.001","article-title":"A case of rhabdomyolysis in which levetiracetam was suspected as the cause","author":"Akiyama","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"key":"key-10.4103\/1817-1745.288298-6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebcr.2014.09.008","article-title":"Creatine phosphokinase elevation exacerbated by levetiracetam therapy","author":"Isaacson","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"key":"key-10.4103\/1817-1745.288298-7","doi-asserted-by":"crossref","first-page":"E176","DOI":"10.1002\/mus.25972","article-title":"Levetiracetam-induced rhabdomyolysis: analysis of reports from the food and drug administration\u2019s adverse event reporting system database","author":"Carnovale","year":"2017","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/1817-1745.288298-8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13760-015-0542-9","article-title":"Acute rhabdomyolysis associated with levetiracetam therapy in a child","author":"Incecik","year":"2016","journal-title":"Acta Neurol Belg"},{"key":"key-10.4103\/1817-1745.288298-9","first-page":"489","article-title":"From the Commission on Classification and Terminology of the International League Against Epilepsy","author":"Proposal","year":"1981","journal-title":"Epilepsia"},{"key":"key-10.4103\/1817-1745.288298-10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0960-8966(01)00228-0","article-title":"Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency","author":"Kottlors","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"key-10.4103\/1817-1745.288298-11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5414\/CPP43436","article-title":"Unsuspected rhabdomyolysis associated with phenytoin","author":"Santos-Calle","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/1817-1745.288298-12","first-page":"E1","article-title":"Rhabdomyolysis associated with levetiracetam administration","author":"Di","year":"2017","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/1817-1745.288298-13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mus.10053","article-title":"Rhabdomyolysis: a review","author":"Warren","year":"2002","journal-title":"Muscle Nerve"}],"container-title":["Journal of Pediatric Neurosciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:14Z","timestamp":1786733234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpn.JPN_133_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["288298"],"URL":"https:\/\/doi.org\/10.4103\/jpn.jpn_133_18","relation":{},"ISSN":["1817-1745"],"issn-type":[{"value":"1817-1745","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}